Resmed (RSMDF) Change in Cash (2009 - 2026)

Resmed (RSMDF) has reported Change in Cash for 18 consecutive years, with -$191.3 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Change in Cash fell 169.12% year-over-year to -$191.3 million; the trailing twelve-month figure through Jun 2026 stood at $259.8 million (down 73.25% YoY), and the FY2026 full-year result was $259.8 million, down 73.25% from the prior year.
• Change in Cash fell to -$191.3 million in Q2 2026 per RSMDF's latest filing, from $243.4 million in the prior quarter.
• Across five years, Change in Cash topped out at $410.8 million in Q1 2025 and bottomed at -$191.3 million in Q2 2026.
• Historically, Change in Cash has averaged $70.8 million across 5 years, with a median of $30.4 million in 2024.
• The sharpest annual moves came in 2023 and 2025: Change in Cash plunged 446.98% in 2023, then surged 61261.2% in 2025.
• Over 5 years, Change in Cash stood at $46.0 million in 2022, then tumbled by 97.51% to $1.1 million in 2023, then soared by 8233.3% to $95.6 million in 2024, then tumbled by 65.24% to $33.2 million in 2025, then tumbled by 675.78% to -$191.3 million in 2026.
• According to Business Quant data, Change in Cash over the past three periods registered -$191.3 million, $243.4 million, and $33.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.